dc.date.accessioned2016-12-01T21:36:07Z
dc.date.available2016-12-01T21:36:07Z
dc.date.created2016-12-01T21:36:07Z
dc.date.issued2014
dc.identifier0108-2701
dc.identifierhttp://hdl.handle.net/10533/136138
dc.identifier1140306
dc.identifierWOS:000341814200002
dc.identifier1600-5759
dc.languageeng
dc.publisherBLACKWELL MUNKSGAARD
dc.relationhttps://doi.org/10.1107/S2053229614017173
dc.relation10.1107/S2053229614017173
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/1140306
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleOn substituted pyrazole derivatives. I. 3-methyl-4-[(z)-2-(4-methylphenyl)hydrazin-1-ylidene]-1-(3-nitrophenyl)-1h-pyrazol-5(4h)-one and 3-methyl-4-[(z)-2-(4-methylphenyl)hydrazin-1-ylidene]-1-[4-(trifluoromethyl)- phenyl]-1h-pyrazol-5(4h)-one
dc.typeArticulo


Este ítem pertenece a la siguiente institución